| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase activity | 2.69e-04 | 30 | 84 | 3 | GO:0004693 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein kinase activity | 2.69e-04 | 30 | 84 | 3 | GO:0097472 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 4.64e-04 | 36 | 84 | 3 | GO:0019789 | |
| GeneOntologyMolecularFunction | RNA polymerase II CTD heptapeptide repeat kinase activity | 7.70e-04 | 10 | 84 | 2 | GO:0008353 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 8.45e-04 | 363 | 84 | 7 | GO:0106310 | |
| GeneOntologyMolecularFunction | voltage-gated chloride channel activity | 9.38e-04 | 11 | 84 | 2 | GO:0005247 | |
| GeneOntologyBiologicalProcess | RNA splicing | TAF6L PPIG CDK12 CLK2 CDK13 SRRM4 LMNTD2 NCBP1 SRSF11 PRPF38B SREK1 THRAP3 RBM39 IWS1 | 1.43e-08 | 502 | 84 | 14 | GO:0008380 |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 2.04e-06 | 207 | 84 | 8 | GO:0043484 | |
| GeneOntologyBiologicalProcess | mRNA processing | CDK12 CDK13 SRRM4 LMNTD2 NCBP1 SRSF11 PRPF38B SREK1 CDK11B THRAP3 RBM39 IWS1 | 2.30e-06 | 551 | 84 | 12 | GO:0006397 |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 3.74e-06 | 158 | 84 | 7 | GO:0050684 | |
| GeneOntologyBiologicalProcess | RNA processing | TAF6L PPIG DCAF13 TSR1 CDK12 CLK2 CDK13 SRRM4 LMNTD2 NCBP1 SRSF11 PRPF38B SREK1 CDK11B LYAR THRAP3 RBM39 RBFA IWS1 | 7.23e-06 | 1500 | 84 | 19 | GO:0006396 |
| GeneOntologyBiologicalProcess | negative regulation of telomeric DNA binding | 1.64e-05 | 2 | 84 | 2 | GO:1904743 | |
| GeneOntologyBiologicalProcess | regulation of telomeric DNA binding | 9.78e-05 | 4 | 84 | 2 | GO:1904742 | |
| GeneOntologyBiologicalProcess | transcription elongation by RNA polymerase II | 1.71e-04 | 127 | 84 | 5 | GO:0006368 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 1.84e-04 | 129 | 84 | 5 | GO:0048024 | |
| GeneOntologyBiologicalProcess | alternative mRNA splicing, via spliceosome | 3.05e-04 | 79 | 84 | 4 | GO:0000380 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription elongation | 3.07e-04 | 144 | 84 | 5 | GO:0006354 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | CDK12 CDK13 SRRM4 LMNTD2 NCBP1 SRSF11 PRPF38B SREK1 CDK11B THRAP3 RBM39 IWS1 | 3.28e-04 | 917 | 84 | 12 | GO:0016071 |
| GeneOntologyBiologicalProcess | endothelial cell chemotaxis | 3.88e-04 | 35 | 84 | 3 | GO:0035767 | |
| GeneOntologyCellularComponent | nuclear body | CASP8AP2 BPNT2 PPIG RAD18 CDK12 CLK2 CDK13 SRSF11 TNKS SREK1 TOPORS THRAP3 RBM39 SP140 | 6.47e-06 | 903 | 79 | 14 | GO:0016604 |
| GeneOntologyCellularComponent | nuclear speck | 3.56e-05 | 431 | 79 | 9 | GO:0016607 | |
| GeneOntologyCellularComponent | transcription elongation factor complex | 5.98e-05 | 56 | 79 | 4 | GO:0008023 | |
| GeneOntologyCellularComponent | transferase complex | RTF1 PHF1 TAF6L UBR1 RAD18 DCAF13 TMEM183A CDK12 CDK13 TMEM183BP CDK11B TOPORS | 2.53e-04 | 963 | 79 | 12 | GO:1990234 |
| GeneOntologyCellularComponent | cyclin/CDK positive transcription elongation factor complex | 4.99e-04 | 9 | 79 | 2 | GO:0008024 | |
| HumanPheno | Recurrent joint dislocation | 1.10e-05 | 14 | 17 | 3 | HP:0031869 | |
| Domain | TMEM183 | 1.95e-05 | 2 | 83 | 2 | IPR026509 | |
| Domain | DUF3446 | 5.84e-05 | 3 | 83 | 2 | IPR021849 | |
| Domain | DUF3446 | 5.84e-05 | 3 | 83 | 2 | PF11928 | |
| Domain | NAC | 1.93e-04 | 5 | 83 | 2 | SM01407 | |
| Domain | HSR | 1.93e-04 | 5 | 83 | 2 | PS51414 | |
| Domain | HSR | 1.93e-04 | 5 | 83 | 2 | PF03172 | |
| Domain | HSR_dom | 1.93e-04 | 5 | 83 | 2 | IPR004865 | |
| Domain | NAC | 2.89e-04 | 6 | 83 | 2 | PF01849 | |
| Domain | Nas_poly-pep-assoc_cplx_dom | 2.89e-04 | 6 | 83 | 2 | IPR002715 | |
| Domain | NAC_AB | 2.89e-04 | 6 | 83 | 2 | PS51151 | |
| Domain | SAND_dom | 5.37e-04 | 8 | 83 | 2 | IPR000770 | |
| Domain | SAND | 5.37e-04 | 8 | 83 | 2 | PF01342 | |
| Domain | SAND | 5.37e-04 | 8 | 83 | 2 | PS50864 | |
| Domain | SAND | 5.37e-04 | 8 | 83 | 2 | SM00258 | |
| Domain | Cl-channel_core | 6.88e-04 | 9 | 83 | 2 | IPR014743 | |
| Domain | - | 6.88e-04 | 9 | 83 | 2 | 1.10.3080.10 | |
| Domain | Voltage_CLC | 6.88e-04 | 9 | 83 | 2 | PF00654 | |
| Domain | Cl-channel_volt-gated | 6.88e-04 | 9 | 83 | 2 | IPR001807 | |
| Domain | PROTEIN_KINASE_ATP | 9.86e-04 | 459 | 83 | 8 | PS00107 | |
| Domain | Ser/Thr_kinase_AS | 1.05e-03 | 357 | 83 | 7 | IPR008271 | |
| Domain | S_TKc | 1.09e-03 | 359 | 83 | 7 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 1.14e-03 | 362 | 83 | 7 | PS00108 | |
| Domain | - | 1.25e-03 | 12 | 83 | 2 | 3.10.390.10 | |
| Domain | SAND_dom-like | 1.25e-03 | 12 | 83 | 2 | IPR010919 | |
| Domain | Prot_kinase_dom | 1.47e-03 | 489 | 83 | 8 | IPR000719 | |
| Domain | Pkinase | 1.53e-03 | 381 | 83 | 7 | PF00069 | |
| Domain | PROTEIN_KINASE_DOM | 1.55e-03 | 493 | 83 | 8 | PS50011 | |
| Domain | CBS | 2.25e-03 | 16 | 83 | 2 | SM00116 | |
| Domain | Poly(ADP-ribose)pol_cat_dom | 2.54e-03 | 17 | 83 | 2 | IPR012317 | |
| Domain | PARP_CATALYTIC | 2.54e-03 | 17 | 83 | 2 | PS51059 | |
| Domain | PARP | 2.54e-03 | 17 | 83 | 2 | PF00644 | |
| Domain | - | 2.54e-03 | 17 | 83 | 2 | 3.90.228.10 | |
| Domain | Kinase-like_dom | 2.80e-03 | 542 | 83 | 8 | IPR011009 | |
| Domain | Zinc_finger_PHD-type_CS | 3.03e-03 | 65 | 83 | 3 | IPR019786 | |
| Domain | CBS_dom | 3.52e-03 | 20 | 83 | 2 | IPR000644 | |
| Domain | CBS | 3.52e-03 | 20 | 83 | 2 | PF00571 | |
| Domain | CBS | 3.52e-03 | 20 | 83 | 2 | PS51371 | |
| Domain | PHD | 4.54e-03 | 75 | 83 | 3 | PF00628 | |
| Domain | WGR_domain | 5.05e-03 | 24 | 83 | 2 | IPR008893 | |
| Domain | Znf_PHD-finger | 5.25e-03 | 79 | 83 | 3 | IPR019787 | |
| Domain | TUDOR | 6.37e-03 | 27 | 83 | 2 | SM00333 | |
| Domain | Protein_kinase_ATP_BS | 6.82e-03 | 379 | 83 | 6 | IPR017441 | |
| Domain | PHD | 7.30e-03 | 89 | 83 | 3 | SM00249 | |
| Domain | Znf_PHD | 7.76e-03 | 91 | 83 | 3 | IPR001965 | |
| Domain | Tudor | 7.83e-03 | 30 | 83 | 2 | IPR002999 | |
| Domain | ZF_PHD_2 | 8.73e-03 | 95 | 83 | 3 | PS50016 | |
| Pubmed | RTF1 TAF6L CASP8AP2 PPIG BTF3L4 RAD18 TSR1 CDK12 CDK13 BTF3 NCBP1 PRPF38B CDK11B LYAR THRAP3 IWS1 | 2.42e-09 | 1014 | 84 | 16 | 32416067 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ZNF512B PPIG BTF3L4 BBX TSR1 CDK12 STK38 NCBP1 SRSF11 PRPF38B SREK1 CDK11B LYAR THRAP3 RBM39 IWS1 | 6.06e-09 | 1082 | 84 | 16 | 38697112 |
| Pubmed | 1.06e-08 | 251 | 84 | 9 | 31076518 | ||
| Pubmed | PPIG BBX TSR1 CDK12 NCBP1 SRSF11 PRPF38B SREK1 CDK11B LYAR THRAP3 RBM39 | 1.48e-07 | 713 | 84 | 12 | 29802200 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | CCM2 FAM193A ARID4B CADPS BTF3 CHCHD6 TNKS RBM39 CAVIN2 IWS1 | 2.30e-07 | 475 | 84 | 10 | 31040226 |
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | 3.03e-07 | 269 | 84 | 8 | 29511261 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZNF512B RAD18 BBX ARID4B CDK12 MLLT1 SRSF11 ZDBF2 SREK1 CDK11B LYAR THRAP3 RBM39 | 4.75e-07 | 954 | 84 | 13 | 36373674 |
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | 7.54e-07 | 8 | 84 | 3 | 12634303 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | RTF1 PPIG CCM2 DSC1 CDK12 CLK2 CDK13 MLLT1 SREK1 THRAP3 RBM39 | 9.28e-07 | 695 | 84 | 11 | 23602568 |
| Pubmed | DCAF13 BBX CLCN3 CLCN4 CDK13 MLLT1 NCBP1 KDR SRSF11 SREK1 SLC4A3 THRAP3 ARHGAP21 CAVIN2 RBFA | 1.72e-06 | 1442 | 84 | 15 | 35575683 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 2.14e-06 | 608 | 84 | 10 | 36089195 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | RTF1 PPIG TSR1 CLK2 DGKB SRSF11 PRPF38B SORBS1 SREK1 CDK11B LYAR PKD1L3 STK38L THRAP3 | 2.31e-06 | 1284 | 84 | 14 | 17353931 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZNF512B TAF6L CASP8AP2 PPIG RAD18 BBX ARID4B CDK13 MLLT1 SRSF11 LYAR THRAP3 RBM39 IWS1 | 2.53e-06 | 1294 | 84 | 14 | 30804502 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | UBR1 PPIG RAD18 ARID4B CDK12 CDK13 PRPF38B CDK11B TOPORS THRAP3 IWS1 | 2.62e-06 | 774 | 84 | 11 | 15302935 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 2.74e-06 | 361 | 84 | 8 | 26167880 | |
| Pubmed | 2.94e-06 | 12 | 84 | 3 | 19884882 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | PPIG DCAF13 CDK13 BTF3 NCBP1 SRSF11 SREK1 CDK11B LYAR THRAP3 RBM39 | 3.91e-06 | 807 | 84 | 11 | 22681889 |
| Pubmed | 4.49e-06 | 272 | 84 | 7 | 31010829 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | FAM193A TSR1 CDK12 CDK13 NCBP1 SRSF11 SREK1 LYAR THRAP3 RBM39 | 5.60e-06 | 678 | 84 | 10 | 30209976 |
| Pubmed | Uncoupling endosomal CLC chloride/proton exchange causes severe neurodegeneration. | 5.76e-06 | 2 | 84 | 2 | 32118314 | |
| Pubmed | NDR functions as a physiological YAP1 kinase in the intestinal epithelium. | 5.76e-06 | 2 | 84 | 2 | 25601544 | |
| Pubmed | Origination and evolution of a human-specific transmembrane protein gene, c1orf37-dup. | 5.76e-06 | 2 | 84 | 2 | 16644869 | |
| Pubmed | EGR3 as a potential susceptibility gene for schizophrenia in Korea. | 5.76e-06 | 2 | 84 | 2 | 20687139 | |
| Pubmed | Human CDK12 and CDK13, multi-tasking CTD kinases for the new millenium. | 5.76e-06 | 2 | 84 | 2 | 30319007 | |
| Pubmed | Egr-2 and Egr-3 are negative regulators of T cell activation. | 5.76e-06 | 2 | 84 | 2 | 15834410 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 29314730 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 25561469 | ||
| Pubmed | Preferential association with ClC-3 permits sorting of ClC-4 into endosomal compartments. | 5.76e-06 | 2 | 84 | 2 | 28972156 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 23485457 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 24999027 | ||
| Pubmed | Dual Inhibition of CDK12/CDK13 Targets Both Tumor and Immune Cells in Ovarian Cancer. | 5.76e-06 | 2 | 84 | 2 | 35857807 | |
| Pubmed | Immune chromatin reader SP140 regulates microbiota and risk for inflammatory bowel disease. | 5.76e-06 | 2 | 84 | 2 | 36130593 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 23021953 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 28487311 | ||
| Pubmed | CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1. | 5.76e-06 | 2 | 84 | 2 | 20952539 | |
| Pubmed | Emerging roles of Egr2 and Egr3 in the control of systemic autoimmunity. | 5.76e-06 | 2 | 84 | 2 | 27856665 | |
| Pubmed | Egr2 and 3 control inflammation, but maintain homeostasis, of PD-1high memory phenotype CD4 T cells. | 5.76e-06 | 2 | 84 | 2 | 32709717 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 15037617 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 35952671 | ||
| Pubmed | The role of Sp140 revealed in IgE and mast cell responses in Collaborative Cross mice. | 5.76e-06 | 2 | 84 | 2 | 34156030 | |
| Pubmed | Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells. | 5.76e-06 | 2 | 84 | 2 | 36342511 | |
| Pubmed | 7.22e-06 | 191 | 84 | 6 | 20195357 | ||
| Pubmed | DCAF13 CLK2 CDK13 BTF3 SRRM4 SRSF11 PRPF38B SREK1 LYAR THRAP3 | 9.80e-06 | 723 | 84 | 10 | 34133714 | |
| Pubmed | Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. | 1.08e-05 | 18 | 84 | 3 | 20064376 | |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 1.19e-05 | 316 | 84 | 7 | 31665637 | |
| Pubmed | 1.21e-05 | 209 | 84 | 6 | 36779422 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | ARFGEF3 CASP8AP2 RAD18 CEP131 ZDBF2 SORBS1 CDK11B CGNL1 TOPORS | 1.27e-05 | 588 | 84 | 9 | 38580884 |
| Pubmed | TAF6L BTF3L4 BBX TSR1 CDK12 CDK13 BTF3 MLLT1 PRPF38B CEP131 SREK1 LYAR RBFA IWS1 | 1.33e-05 | 1497 | 84 | 14 | 31527615 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.59e-05 | 605 | 84 | 9 | 28977666 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | PPIG DCAF13 TSR1 CLK2 BTF3 NCBP1 SRSF11 PRPF38B SREK1 CDK11B LYAR THRAP3 RBM39 | 1.61e-05 | 1318 | 84 | 13 | 30463901 |
| Pubmed | Human NDR kinases control G(1)/S cell cycle transition by directly regulating p21 stability. | 1.73e-05 | 3 | 84 | 2 | 21262772 | |
| Pubmed | E3 ligase Rad18 promotes monoubiquitination rather than ubiquitin chain formation by E2 enzyme Rad6. | 1.73e-05 | 3 | 84 | 2 | 21422291 | |
| Pubmed | Early growth response transcriptional regulators are dispensable for macrophage differentiation. | 1.73e-05 | 3 | 84 | 2 | 17312150 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 15173177 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 23897809 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 33011290 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 35045301 | ||
| Pubmed | Egr2 and 3 Inhibit T-bet-Mediated IFN-γ Production in T Cells. | 1.73e-05 | 3 | 84 | 2 | 28455436 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 27911796 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 25979336 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 15466487 | ||
| Pubmed | HIV-1 incorporates and proteolytically processes human NDR1 and NDR2 serine-threonine kinases. | 1.73e-05 | 3 | 84 | 2 | 15582665 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 37026485 | ||
| Pubmed | Epidermal-growth-factor-induced proliferation of astrocytes requires Egr transcription factors. | 1.73e-05 | 3 | 84 | 2 | 19706684 | |
| Pubmed | 2.62e-05 | 645 | 84 | 9 | 25281560 | ||
| Pubmed | UPF2 is a critical regulator of liver development, function and regeneration. | 2.65e-05 | 24 | 84 | 3 | 20657840 | |
| Pubmed | 2.96e-05 | 655 | 84 | 9 | 35819319 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | RAD18 DCAF13 ERCC4 IPO8 DSC1 SP140L CDK12 NCBP1 PRPF38B TNKS TOPORS THRAP3 | 3.16e-05 | 1203 | 84 | 12 | 29180619 |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 34151776 | ||
| Pubmed | An amphioxus Krox gene: insights into vertebrate hindbrain evolution. | 3.45e-05 | 4 | 84 | 2 | 11180801 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 20351103 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 19062280 | ||
| Pubmed | Mechanism of activation of NDR (nuclear Dbf2-related) protein kinase by the hMOB1 protein. | 3.45e-05 | 4 | 84 | 2 | 15197186 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 20506119 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 22012619 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 11891986 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 3.52e-05 | 670 | 84 | 9 | 22990118 | |
| Pubmed | 3.60e-05 | 153 | 84 | 5 | 10718198 | ||
| Pubmed | 3.69e-05 | 255 | 84 | 6 | 15324660 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 4.01e-05 | 853 | 84 | 10 | 28718761 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ARFGEF3 BTF3L4 CLK2 CDK13 LRP5 CHCHD6 SRSF11 PRPF38B TMEM183BP STK38L THRAP3 RBM39 WNK2 | 5.68e-05 | 1489 | 84 | 13 | 28611215 |
| Pubmed | Integrated analysis of DNA methylation and RNA‑sequencing data in Down syndrome. | 5.74e-05 | 5 | 84 | 2 | 27667480 | |
| Pubmed | Piezo2 expressed in proprioceptive neurons is essential for skeletal integrity. | 5.74e-05 | 5 | 84 | 2 | 32576830 | |
| Pubmed | Egr2-independent, Klf1-mediated induction of PD-L1 in CD4+ T cells. | 5.74e-05 | 5 | 84 | 2 | 29728568 | |
| Pubmed | Ndr kinases regulate retinal interneuron proliferation and homeostasis. | 5.74e-05 | 5 | 84 | 2 | 30135513 | |
| Pubmed | Opposing regulation of T cell function by Egr-1/NAB2 and Egr-2/Egr-3. | 5.74e-05 | 5 | 84 | 2 | 18203138 | |
| Pubmed | HIV Tat binds Egr proteins and enhances Egr-dependent transactivation of the Fas ligand promoter. | 5.74e-05 | 5 | 84 | 2 | 11909874 | |
| Pubmed | Cyclin K-containing kinase complexes maintain self-renewal in murine embryonic stem cells. | 5.74e-05 | 5 | 84 | 2 | 22547058 | |
| Pubmed | Id3 Restricts γδ NKT Cell Expansion by Controlling Egr2 and c-Myc Activity. | 5.74e-05 | 5 | 84 | 2 | 30012846 | |
| Pubmed | Human Mob proteins regulate the NDR1 and NDR2 serine-threonine kinases. | 5.74e-05 | 5 | 84 | 2 | 15067004 | |
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 19169262 | ||
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 19339555 | ||
| Pubmed | 6.82e-05 | 730 | 84 | 9 | 34857952 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | RTF1 CDK12 CLK2 CDK13 STK38 MLLT1 CDK11B STK38L THRAP3 ARHGAP21 | 6.88e-05 | 910 | 84 | 10 | 36736316 |
| Pubmed | 6.89e-05 | 731 | 84 | 9 | 29298432 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ZNF512B BTF3L4 FAM193A DSC1 CDK12 BTF3 PRPF38B CGNL1 RBM39 ARHGAP21 | 8.53e-05 | 934 | 84 | 10 | 33916271 |
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 35355521 | ||
| Pubmed | Expression of CLCN voltage-gated chloride channel genes in human blood vessels. | 8.59e-05 | 6 | 84 | 2 | 10198195 | |
| Pubmed | Structure and vascular function of MEKK3-cerebral cavernous malformations 2 complex. | 8.59e-05 | 6 | 84 | 2 | 26235885 | |
| Pubmed | Loss of NDR1/2 kinases impairs endomembrane trafficking and autophagy leading to neurodegeneration. | 8.59e-05 | 6 | 84 | 2 | 36446521 | |
| Interaction | CLK3 interactions | PPIG RAD18 CLK2 MLLT1 NCBP1 SRSF11 PRPF38B LYAR TOPORS THRAP3 RBM39 | 1.89e-09 | 220 | 84 | 11 | int:CLK3 |
| Interaction | SRPK2 interactions | RTF1 ARFGEF3 PPIG RAD18 CCM2 CDK12 CLK2 CDK13 BTF3 NCBP1 SRSF11 PRPF38B SREK1 LYAR THRAP3 RBM39 CAVIN2 | 5.35e-09 | 717 | 84 | 17 | int:SRPK2 |
| Interaction | SRSF4 interactions | PPIG RAD18 CDK12 CLK2 CDK13 SRRM4 SRSF11 SREK1 TOPORS THRAP3 RBM39 | 4.69e-08 | 300 | 84 | 11 | int:SRSF4 |
| Interaction | DDX23 interactions | RTF1 ZNF512B PPIG RAD18 CDK12 CDK13 MLLT1 SRSF11 SREK1 LYAR THRAP3 RBM39 IWS1 | 9.06e-08 | 480 | 84 | 13 | int:DDX23 |
| Interaction | EZH1 interactions | 1.12e-07 | 92 | 84 | 7 | int:EZH1 | |
| Interaction | LINC02910 interactions | 1.39e-07 | 95 | 84 | 7 | int:LINC02910 | |
| Interaction | SNIP1 interactions | RTF1 PPIG RAD18 CCM2 DCAF13 CLK2 CDK13 BTF3 SRRM4 NCBP1 TOPORS THRAP3 | 1.55e-07 | 417 | 84 | 12 | int:SNIP1 |
| Interaction | SRSF6 interactions | PPIG BBX CDK12 CLK2 CDK13 BTF3 SRSF11 PRPF38B SREK1 CDK11B TOPORS THRAP3 RBM39 | 1.55e-07 | 503 | 84 | 13 | int:SRSF6 |
| Interaction | SRSF11 interactions | 1.71e-07 | 203 | 84 | 9 | int:SRSF11 | |
| Interaction | SAP18 interactions | PPIG RAD18 ARID4B CLK2 SRSF11 PRPF38B SREK1 TOPORS THRAP3 RBM39 | 5.59e-07 | 305 | 84 | 10 | int:SAP18 |
| Interaction | ANAPC15 interactions | 1.07e-06 | 128 | 84 | 7 | int:ANAPC15 | |
| Interaction | SRPK3 interactions | 1.27e-06 | 190 | 84 | 8 | int:SRPK3 | |
| Interaction | SNRNP70 interactions | PPIG BBX TSR1 CDK12 CLK2 BTF3 SRGAP1 SRRM4 NCBP1 SRSF11 PRPF38B SREK1 CDK11B LYAR THRAP3 RBM39 | 2.58e-06 | 984 | 84 | 16 | int:SNRNP70 |
| Interaction | PIP4K2A interactions | 3.32e-06 | 216 | 84 | 8 | int:PIP4K2A | |
| Interaction | CLK1 interactions | 3.67e-06 | 219 | 84 | 8 | int:CLK1 | |
| Interaction | CDK8 interactions | 4.06e-06 | 222 | 84 | 8 | int:CDK8 | |
| Interaction | MECP2 interactions | ZNF512B PPIG BTF3L4 DCAF13 BBX TSR1 CDK12 BTF3 STK38 NCBP1 SRSF11 PRPF38B SREK1 CDK11B LYAR THRAP3 RBM39 IWS1 | 4.66e-06 | 1287 | 84 | 18 | int:MECP2 |
| Interaction | ZCCHC10 interactions | 6.37e-06 | 236 | 84 | 8 | int:ZCCHC10 | |
| Interaction | LUC7L interactions | 7.65e-06 | 242 | 84 | 8 | int:LUC7L | |
| Interaction | RBBP7 interactions | ZNF512B PHF1 RAD18 ARID4B DSC1 BTF3 PRPF38B CDK11B TOPORS THRAP3 RBM39 | 8.12e-06 | 507 | 84 | 11 | int:RBBP7 |
| Interaction | BCLAF1 interactions | 8.84e-06 | 327 | 84 | 9 | int:BCLAF1 | |
| Interaction | PRP4K interactions | 9.28e-06 | 329 | 84 | 9 | int:PRP4K | |
| Interaction | RNPS1 interactions | PPIG CDK12 CLK2 SRRM4 SRSF11 SREK1 CDK11B TOPORS THRAP3 RBM39 | 1.07e-05 | 425 | 84 | 10 | int:RNPS1 |
| Interaction | SUPT16H interactions | 1.51e-05 | 442 | 84 | 10 | int:SUPT16H | |
| Interaction | THRAP3 interactions | 1.54e-05 | 443 | 84 | 10 | int:THRAP3 | |
| Interaction | ZNF330 interactions | 1.63e-05 | 446 | 84 | 10 | int:ZNF330 | |
| Interaction | SRRM4 interactions | 1.67e-05 | 37 | 84 | 4 | int:SRRM4 | |
| Interaction | TERF2IP interactions | RTF1 ZNF512B TAF6L RAD18 ERCC4 BBX CDK12 CDK13 NCBP1 SRSF11 SREK1 | 1.79e-05 | 552 | 84 | 11 | int:TERF2IP |
| Interaction | NKAP interactions | 1.88e-05 | 132 | 84 | 6 | int:NKAP | |
| Interaction | RAD18 interactions | PPIG RAD18 CDK12 CLK2 SRGAP1 NCBP1 PRPF38B CDK11B THRAP3 IWS1 | 2.01e-05 | 457 | 84 | 10 | int:RAD18 |
| Interaction | SRSF1 interactions | PPIG TSR1 CDK12 CLK2 CDK13 BTF3 SRSF11 SREK1 LYAR THRAP3 RBM39 | 2.41e-05 | 570 | 84 | 11 | int:SRSF1 |
| Interaction | PARP1 interactions | RTF1 ZNF512B TAF6L BPNT2 RAD18 ERCC4 BBX ARID4B CDK13 BTF3 MLLT1 SREK1 CGNL1 LYAR TOPORS THRAP3 RBM39 | 2.52e-05 | 1316 | 84 | 17 | int:PARP1 |
| Interaction | IK interactions | 3.22e-05 | 215 | 84 | 7 | int:IK | |
| Interaction | ACIN1 interactions | 3.68e-05 | 301 | 84 | 8 | int:ACIN1 | |
| Interaction | PNN interactions | 3.77e-05 | 302 | 84 | 8 | int:PNN | |
| Interaction | CSNK2A1 interactions | RTF1 BTF3L4 RAD18 ARID4B TSR1 CDK12 CLK2 MLLT1 SRSF11 SREK1 CDK11B THRAP3 RBM39 IWS1 | 3.80e-05 | 956 | 84 | 14 | int:CSNK2A1 |
| Interaction | SHPRH interactions | 5.32e-05 | 97 | 84 | 5 | int:SHPRH | |
| Interaction | YWHAE interactions | RAD18 IPO8 CDK12 CDK13 BTF3 SRGAP1 NCBP1 CEP131 SORBS1 CDK11B CGNL1 STK38L PLEKHG5 RBM39 ARHGAP21 WNK2 | 5.37e-05 | 1256 | 84 | 16 | int:YWHAE |
| Interaction | NUP43 interactions | RTF1 CASP8AP2 BBX ARID4B DSC1 CDK12 ZDBF2 SREK1 CDK11B RBM39 IWS1 | 5.57e-05 | 625 | 84 | 11 | int:NUP43 |
| Interaction | PNISR interactions | 6.04e-05 | 51 | 84 | 4 | int:PNISR | |
| Interaction | H3-3A interactions | ZNF512B RAD18 BBX ARID4B TSR1 BTF3 NCBP1 CDK11B LYAR ZNF649 THRAP3 IWS1 | 6.17e-05 | 749 | 84 | 12 | int:H3-3A |
| Interaction | ZC3H18 interactions | RTF1 PPIG RAD18 DSC1 CDK12 CLK2 NCBP1 SRSF11 PRPF38B LYAR TOPORS THRAP3 RBM39 | 6.56e-05 | 877 | 84 | 13 | int:ZC3H18 |
| Interaction | TRA2A interactions | 7.02e-05 | 330 | 84 | 8 | int:TRA2A | |
| Interaction | UQCR11 interactions | 7.04e-05 | 53 | 84 | 4 | int:UQCR11 | |
| Interaction | JARID2 interactions | 7.58e-05 | 54 | 84 | 4 | int:JARID2 | |
| Interaction | IFI6 interactions | 7.58e-05 | 54 | 84 | 4 | int:IFI6 | |
| Interaction | CFAP141 interactions | 8.15e-05 | 55 | 84 | 4 | int:CFAP141 | |
| Interaction | MTA3 interactions | 8.57e-05 | 173 | 84 | 6 | int:MTA3 | |
| Interaction | H3C1 interactions | ZNF512B PHF1 TAF6L BTF3L4 RAD18 PIEZO2 BBX ARID4B TSR1 CDK13 BTF3 MLLT1 THRAP3 | 8.62e-05 | 901 | 84 | 13 | int:H3C1 |
| Interaction | ANKRD50 interactions | 8.88e-05 | 108 | 84 | 5 | int:ANKRD50 | |
| Interaction | ARL6IP4 interactions | 9.28e-05 | 109 | 84 | 5 | int:ARL6IP4 | |
| Interaction | ARHGAP42 interactions | 1.15e-04 | 60 | 84 | 4 | int:ARHGAP42 | |
| Interaction | RPL31 interactions | RTF1 ZNF512B BTF3L4 RAD18 BBX TSR1 BTF3 SREK1 LYAR RBM39 IWS1 | 1.18e-04 | 680 | 84 | 11 | int:RPL31 |
| Interaction | GPATCH8 interactions | 1.20e-04 | 115 | 84 | 5 | int:GPATCH8 | |
| Interaction | SSRP1 interactions | RTF1 RAD18 RHOBTB1 BTF3 NCBP1 SREK1 LYAR THRAP3 RBM39 CAVIN2 IWS1 | 1.26e-04 | 685 | 84 | 11 | int:SSRP1 |
| Interaction | SRRM2 interactions | 1.30e-04 | 462 | 84 | 9 | int:SRRM2 | |
| Interaction | RBBP4 interactions | ZNF512B PHF1 RAD18 BBX ARID4B BTF3 CDK11B TOPORS THRAP3 RBM39 | 1.33e-04 | 573 | 84 | 10 | int:RBBP4 |
| Interaction | GSK3A interactions | ARFGEF3 FAM193A TSR1 BTF3 CEP131 ZDBF2 TOPORS THRAP3 ARHGAP21 | 1.34e-04 | 464 | 84 | 9 | int:GSK3A |
| Interaction | H2BC8 interactions | 1.39e-04 | 576 | 84 | 10 | int:H2BC8 | |
| Interaction | TOP1 interactions | RAD18 DCAF13 ARID4B TSR1 BTF3 NCBP1 SRSF11 TOPORS THRAP3 RBM39 IWS1 | 1.45e-04 | 696 | 84 | 11 | int:TOP1 |
| Interaction | IFI27L1 interactions | 1.57e-04 | 65 | 84 | 4 | int:IFI27L1 | |
| Interaction | HDGFL2 interactions | 1.61e-04 | 194 | 84 | 6 | int:HDGFL2 | |
| Interaction | CLK2 interactions | 1.65e-04 | 195 | 84 | 6 | int:CLK2 | |
| Interaction | SRPK1 interactions | 1.65e-04 | 477 | 84 | 9 | int:SRPK1 | |
| Interaction | SNRPA interactions | 1.79e-04 | 482 | 84 | 9 | int:SNRPA | |
| Interaction | YWHAG interactions | PPIG CDK12 CLK2 BTF3 SRGAP1 KDR SRSF11 PRPF38B CEP131 SORBS1 CDK11B CGNL1 PLEKHG5 THRAP3 ARHGAP21 | 1.81e-04 | 1248 | 84 | 15 | int:YWHAG |
| Interaction | PPIG interactions | 1.90e-04 | 127 | 84 | 5 | int:PPIG | |
| Interaction | MYO1E interactions | 2.00e-04 | 202 | 84 | 6 | int:MYO1E | |
| Interaction | PRPH interactions | 2.11e-04 | 204 | 84 | 6 | int:PRPH | |
| Interaction | JMJD6 interactions | 2.16e-04 | 205 | 84 | 6 | int:JMJD6 | |
| Interaction | APEX1 interactions | RTF1 ZNF512B PHF1 RAD18 FAM193A BBX CLCN3 ARID4B CDK13 CEP131 LYAR ABLIM3 PLEKHG5 THRAP3 IWS1 | 2.21e-04 | 1271 | 84 | 15 | int:APEX1 |
| Interaction | LLGL2 interactions | 2.36e-04 | 133 | 84 | 5 | int:LLGL2 | |
| Interaction | SMC5 interactions | ZNF512B RAD18 BBX ARID4B CDK12 MLLT1 SRSF11 ZDBF2 SREK1 CDK11B LYAR THRAP3 RBM39 | 2.42e-04 | 1000 | 84 | 13 | int:SMC5 |
| Interaction | HERC2 interactions | 2.45e-04 | 503 | 84 | 9 | int:HERC2 | |
| Interaction | ANKRD20A4P interactions | 2.55e-04 | 6 | 84 | 2 | int:ANKRD20A4P | |
| Interaction | HDAC4 interactions | CCM2 FAM193A ARID4B EGR2 CADPS BTF3 TNKS THRAP3 RBM39 CAVIN2 IWS1 | 2.57e-04 | 744 | 84 | 11 | int:HDAC4 |
| Interaction | CTNNB1 interactions | RAD18 FAM193A EGR2 BTF3 LRP5 KDR PRPF38B TNKS SORBS1 CGNL1 THRAP3 RBM39 ARHGAP21 | 2.64e-04 | 1009 | 84 | 13 | int:CTNNB1 |
| Interaction | PSPC1 interactions | 2.91e-04 | 515 | 84 | 9 | int:PSPC1 | |
| Interaction | SRSF3 interactions | 3.22e-04 | 522 | 84 | 9 | int:SRSF3 | |
| Interaction | SF3B5 interactions | 3.30e-04 | 143 | 84 | 5 | int:SF3B5 | |
| Interaction | CDX1 interactions | 3.49e-04 | 80 | 84 | 4 | int:CDX1 | |
| Interaction | ANKRD20A2P interactions | 3.56e-04 | 7 | 84 | 2 | int:ANKRD20A2P | |
| Interaction | UBE2A interactions | 3.65e-04 | 226 | 84 | 6 | int:UBE2A | |
| Interaction | PSENEN interactions | 3.66e-04 | 81 | 84 | 4 | int:PSENEN | |
| Interaction | CDK12 interactions | 3.83e-04 | 228 | 84 | 6 | int:CDK12 | |
| Interaction | BARD1 interactions | 4.01e-04 | 323 | 84 | 7 | int:BARD1 | |
| Interaction | RHOBTB1 interactions | 4.37e-04 | 152 | 84 | 5 | int:RHOBTB1 | |
| Interaction | RC3H2 interactions | FAM193A TSR1 CDK12 CDK13 NCBP1 SRSF11 SREK1 LYAR THRAP3 RBM39 | 4.48e-04 | 667 | 84 | 10 | int:RC3H2 |
| Interaction | RC3H1 interactions | FAM193A TSR1 CDK12 STK38 NCBP1 SREK1 LYAR STK38L THRAP3 RBM39 | 5.04e-04 | 677 | 84 | 10 | int:RC3H1 |
| Interaction | NKAPD1 interactions | 5.68e-04 | 161 | 84 | 5 | int:NKAPD1 | |
| Interaction | PRPF38A interactions | 5.68e-04 | 161 | 84 | 5 | int:PRPF38A | |
| Interaction | HNRNPCL1 interactions | 5.68e-04 | 161 | 84 | 5 | int:HNRNPCL1 | |
| Interaction | SRGAP1 interactions | 5.94e-04 | 92 | 84 | 4 | int:SRGAP1 | |
| Interaction | ZRSR2P1 interactions | 6.06e-04 | 9 | 84 | 2 | int:ZRSR2P1 | |
| Interaction | NOP56 interactions | 6.08e-04 | 570 | 84 | 9 | int:NOP56 | |
| Interaction | PPP1R15A interactions | 6.17e-04 | 40 | 84 | 3 | int:PPP1R15A | |
| Interaction | MAGEB2 interactions | 6.36e-04 | 349 | 84 | 7 | int:MAGEB2 | |
| Interaction | INO80B interactions | 6.70e-04 | 167 | 84 | 5 | int:INO80B | |
| Interaction | LUC7L2 interactions | 6.80e-04 | 353 | 84 | 7 | int:LUC7L2 | |
| Interaction | SRSF8 interactions | 7.53e-04 | 98 | 84 | 4 | int:SRSF8 | |
| GeneFamily | Cyclin dependent kinases | 5.90e-05 | 26 | 53 | 3 | 496 | |
| GeneFamily | Chloride voltage-gated channels | 3.74e-04 | 10 | 53 | 2 | 302 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 1.11e-03 | 17 | 53 | 2 | 684 | |
| GeneFamily | PHD finger proteins | 2.33e-03 | 90 | 53 | 3 | 88 | |
| Coexpression | GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_PMA_STIM_UP | 3.74e-06 | 200 | 84 | 7 | M6356 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 2.19e-05 | 363 | 84 | 8 | M41103 | |
| Coexpression | BENPORATH_SOX2_TARGETS | UBR1 BTF3L4 ARID4B EGR3 CDK12 NCBP1 KDR CEP131 PPP1R15A RBM39 IWS1 | 2.23e-05 | 734 | 84 | 11 | M3835 |
| Coexpression | GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_UP | 4.54e-05 | 200 | 84 | 6 | M4827 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CASP8AP2 PPIG RAD18 PIEZO2 BBX ARID4B SRSF11 PRPF38B SREK1 IWS1 | 4.70e-05 | 656 | 84 | 10 | M18979 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 7.45e-05 | 432 | 84 | 8 | M41149 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | RTF1 BTF3L4 IPO8 TMEM183A TSR1 BTF3 STK38 NCBP1 SRSF11 TMEM183BP TNKS THRAP3 IWS1 | 7.73e-05 | 1158 | 84 | 13 | MM1338 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | CASP8AP2 PPIG FAM193A ARID4B CLK2 SRGAP1 PRPF38B CDK11B LYAR ARHGAP21 IWS1 | 3.53e-08 | 311 | 83 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | CASP8AP2 PPIG FAM193A CLCN3 ARID4B CLK2 SRGAP1 SRRM4 DGKB NCBP1 SRSF11 PRPF38B ZDBF2 CDK11B LYAR ARHGAP21 WNK2 IWS1 | 3.88e-08 | 989 | 83 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CASP8AP2 PPIG BTF3L4 RAD18 FAM193A ARID4B IPO8 CLK2 SRSF11 PRPF38B ZDBF2 ZNF518B SREK1 CDK11B LYAR TOPORS THRAP3 ARHGAP21 IWS1 | 2.80e-07 | 1257 | 83 | 19 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | CASP8AP2 PPIG BTF3L4 RAD18 FAM193A ARID4B IPO8 CLK2 SRSF11 PRPF38B ZDBF2 ZNF518B SREK1 CDK11B LYAR TOPORS THRAP3 ARHGAP21 IWS1 | 2.63e-06 | 1459 | 83 | 19 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | CASP8AP2 BBX TSR1 CDK12 NCBP1 ZDBF2 ZNF518B LYAR TOPORS THRAP3 IWS1 | 6.97e-06 | 532 | 83 | 11 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.03e-05 | 192 | 83 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | EB amniotic fluid MSC_vs_EB blastocyst-Confounder_removed-fold2.0_adjp0.05 | EGR2 EGR3 CADPS SRRM4 HES4 LMNTD2 ZDBF2 SMPD3 PPP1R15A PLEKHG5 SLC4A3 WNK2 | 2.47e-05 | 727 | 83 | 12 | PCBC_ratio_EB amniotic fluid MSC_vs_EB blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 8.96e-05 | 469 | 83 | 9 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | CASP8AP2 PPIG FAM193A CLK2 SRGAP1 DGKB NCBP1 ZDBF2 CDK11B LYAR ARHGAP21 IWS1 | 8.98e-05 | 831 | 83 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 8.99e-05 | 186 | 83 | 6 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.02e-04 | 275 | 83 | 7 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 1.07e-04 | 192 | 83 | 6 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 1.41e-04 | 498 | 83 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.44e-04 | 291 | 83 | 7 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | CASP8AP2 PPIG RAD18 ARID4B IPO8 CADPS CLK2 PRPF38B ZDBF2 ZNF518B CDK11B THRAP3 ARHGAP21 WNK2 ZNF710 | 2.46e-04 | 1370 | 83 | 15 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | CASP8AP2 PPIG ARID4B CLK2 PRPF38B CEP131 ZDBF2 ZNF518B SREK1 CDK11B PPP1R15A LYAR TOPORS THRAP3 | 3.01e-04 | 1241 | 83 | 14 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | TAF6L PPIG BBX ARID4B EGR2 SRRM4 SRSF11 PRPF38B CDK11B PPP1R15A LYAR IWS1 | 4.46e-04 | 989 | 83 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 6.38e-08 | 186 | 84 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.86e-08 | 188 | 84 | 7 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 9.44e-08 | 197 | 84 | 7 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-06 | 178 | 84 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.43e-06 | 186 | 84 | 6 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 194 | 84 | 6 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.00e-06 | 197 | 84 | 6 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 6.41e-06 | 138 | 84 | 5 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | COVID-19-Myeloid-MoAM5,_CCL3L1|Myeloid / Condition, Lineage and Cell class | 1.66e-05 | 168 | 84 | 5 | ea465152ea31391b63c02425beafa9a4f51f6703 | |
| ToppCell | COVID-19-Myeloid-MoAM5,_CCL3L1|COVID-19 / Condition, Lineage and Cell class | 1.92e-05 | 173 | 84 | 5 | 502f888b7684ed39f5c577eedcacf673ae81d39e | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l7|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.97e-05 | 174 | 84 | 5 | b1bcd5f4505d2ccef4183fcfbf1de81964b3f9e0 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Pulmonary_neuroendocrine|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.71e-05 | 186 | 84 | 5 | fcabebdfbf1b1dbb35ce2b3c53a60d2b1aed8e6c | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 187 | 84 | 5 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.85e-05 | 188 | 84 | 5 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.85e-05 | 188 | 84 | 5 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-05 | 189 | 84 | 5 | 1be5067c1e45af7d09c1fd6955952cb9e031a3a0 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-05 | 189 | 84 | 5 | 30dc1725d43a60017fb12d706f1f85a33de4947e | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.00e-05 | 190 | 84 | 5 | 106ea0bb7b99c697ffc5443d72343df2484250c7 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-05 | 191 | 84 | 5 | 8e8beb8e8a3b33cac83d3f7ce915a71e3654fdab | |
| ToppCell | COVID-19_Convalescent-PLT_4|COVID-19_Convalescent / Disease Group and Platelet Clusters | 3.32e-05 | 194 | 84 | 5 | ce1fad4e76a87f0c35e430ed1f2262395df882fd | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-05 | 195 | 84 | 5 | f41a68b7c2621594db8d8952e301eeadc96be26f | |
| ToppCell | COVID-19_Severe-PLT_4|World / Disease Group and Platelet Clusters | 3.48e-05 | 196 | 84 | 5 | ad43efdd4d73b6615f65f06a315b33576e317473 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.57e-05 | 197 | 84 | 5 | 61c1c29a62d4c033999b7f0183c1e9cdd6a62925 | |
| ToppCell | (5)_Dendritic_cell-(53)_Lymphoid_DC|(5)_Dendritic_cell / shred on Cell_type and subtype | 3.65e-05 | 198 | 84 | 5 | 548da5fa86f9756c503ed77bcdde55bc4d1a2726 | |
| ToppCell | COVID-19_Severe-PLT_4|COVID-19_Severe / Disease Group and Platelet Clusters | 3.65e-05 | 198 | 84 | 5 | abfddbee99ef8c7719e6e6f62571e9be030e4acf | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.65e-05 | 198 | 84 | 5 | 8f25e8dff42bad8e779ca618bdb1cb1610667962 | |
| ToppCell | Control-PLT_4|Control / Disease Group and Platelet Clusters | 3.65e-05 | 198 | 84 | 5 | 387fd3037fd52e4d4c42de0588767e58af228b59 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.65e-05 | 198 | 84 | 5 | 9895f1d65d18d939f3974a914ee41c6d5575e765 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 3.65e-05 | 198 | 84 | 5 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.65e-05 | 198 | 84 | 5 | e3e0aa3ef20b2370f5b133048510677aaa562dfa | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Airway-Club|LPS_only / Treatment groups by lineage, cell group, cell type | 3.74e-05 | 199 | 84 | 5 | 165ac94b2d56072ad43358b5127d77555221e2d8 | |
| ToppCell | Biopsy_IPF-Epithelial-SCGB3A2+_SCGB1A1+|Biopsy_IPF / Sample group, Lineage and Cell type | 3.74e-05 | 199 | 84 | 5 | c6150f5fe2ce4466149a4d553acb907034a72efb | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 3.74e-05 | 199 | 84 | 5 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Neuronal|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 3.74e-05 | 199 | 84 | 5 | b2508bf591720830e8e3494b1337aab14539956d | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Myeloid-Megakaryocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.74e-05 | 199 | 84 | 5 | 6e7f7214317f2af2ba8523df9896f54b7294d58a | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Myeloid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.74e-05 | 199 | 84 | 5 | 5f499595597c10857bba8272f62afe4d32d733ac | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_2|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.83e-05 | 200 | 84 | 5 | 1fa29a9f42987549a75dffeb177099458f7cca88 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.83e-05 | 200 | 84 | 5 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.83e-05 | 200 | 84 | 5 | 7595eb2a8af3de879ecaa71f3d96f890e13b59ce | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.83e-05 | 200 | 84 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Mesenchymal|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 3.83e-05 | 200 | 84 | 5 | 5c638c80661017c85f9390f1b398ac7728c8f001 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Mesenchymal-BMP_responsible_cell|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 3.83e-05 | 200 | 84 | 5 | 604a88633d4162337e394155c7346dbdef8b9f5a | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.83e-05 | 200 | 84 | 5 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.83e-05 | 200 | 84 | 5 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.86e-04 | 150 | 84 | 4 | 57f21ad380fd1350a2c25d75ad8c3b763ded53ec | |
| ToppCell | PBMC-Control-cDC_8|Control / Compartment, Disease Groups and Clusters | 2.01e-04 | 153 | 84 | 4 | db1a6914f2033fb0748e0523cffe5d6dc4e901be | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.22e-04 | 157 | 84 | 4 | 19c0599a669803c4db1f174de1ce755e562a50a3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.33e-04 | 159 | 84 | 4 | 7747cef94c55144fddcd024a7495318357f1351b | |
| ToppCell | moderate-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.74e-04 | 166 | 84 | 4 | c3835b424c63bf11a4e2c47635dc3787fc4a637a | |
| ToppCell | Endothelial-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 2.80e-04 | 167 | 84 | 4 | 6a03d16165e0b003092c39972928981abd4a75aa | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.80e-04 | 167 | 84 | 4 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.87e-04 | 168 | 84 | 4 | a74c8a9e3299183fba31ce3053ef325b5dbcd104 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.87e-04 | 168 | 84 | 4 | dae37b316ce80dfe4236c4ed7f0d4e7c340fa7b6 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.93e-04 | 169 | 84 | 4 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-04 | 172 | 84 | 4 | 073a503dc922e3e3ac3528e249b0f8b74402110b | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.21e-04 | 173 | 84 | 4 | 7dc988fc0ba29990567bf1bcdeb3faeeee507eb1 | |
| ToppCell | Endothelial-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 3.21e-04 | 173 | 84 | 4 | a81992965137195d20fc498f750975303961a828 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 173 | 84 | 4 | 9a04271c51fae34f547db3206f9ff5857686e45c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.35e-04 | 175 | 84 | 4 | 06eace2e681980456299167b48bd49bcfea5e940 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 3.35e-04 | 175 | 84 | 4 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.6.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.35e-04 | 175 | 84 | 4 | baaffc9af61f12168d6f7b96eb0b6e98a44a3909 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.35e-04 | 175 | 84 | 4 | e99e145a152f534b75267ec492a252a0b814b4f8 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 3.35e-04 | 175 | 84 | 4 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Endothelial-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-04 | 176 | 84 | 4 | a3f27b5d7edf2d396c085efbe35305cfa0afa565 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Drd1_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.42e-04 | 176 | 84 | 4 | 3c76a5c4ca2b378667cb155fbb9675519572b35d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-04 | 177 | 84 | 4 | c274fbdc141855ff4581d437d4997c64cc193278 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-04 | 177 | 84 | 4 | f5e6df5cafd003bbfbb3b634ee58d0b1e2be5cc7 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.50e-04 | 177 | 84 | 4 | 779ba86f53650772755b52460be03f18bb204e55 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-04 | 177 | 84 | 4 | c8a51e480b978dc0ded85583261f2c892e085be8 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.50e-04 | 177 | 84 | 4 | 0f210cfb61b873c5fd77dc17eadf4d017306500e | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.50e-04 | 177 | 84 | 4 | b1775e05c28883a15c56628028770bc59d3233fb | |
| ToppCell | facs-Lung-EPCAM-18m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-04 | 177 | 84 | 4 | 2433924dcb085ebbe2545d476ebd7ee68e6092fb | |
| ToppCell | 15-Trachea-Epithelial-Goblet-like_secretory|Trachea / Age, Tissue, Lineage and Cell class | 3.57e-04 | 178 | 84 | 4 | f0557920b9b3e7c4f39938d1b524aa58711af4d2 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.57e-04 | 178 | 84 | 4 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l7|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.57e-04 | 178 | 84 | 4 | a3f95f0002f408b5b6c57e28b297b5b2737e919c | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 178 | 84 | 4 | 93ce73f8bcec63ebf86fabb546f88400e8f06465 | |
| ToppCell | facs-GAT-Fat-18m-Endothelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-04 | 179 | 84 | 4 | d56fa2a0b119d51a8d41b00fbbd7dfddefeb279c | |
| ToppCell | facs-GAT-Fat-18m-Endothelial-endothelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-04 | 179 | 84 | 4 | e0542694fa79d67f67be6f85b4fa6d18f7523253 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 3.65e-04 | 179 | 84 | 4 | 431e1b29015ec817f778499106d24b19cfc825ae | |
| ToppCell | 15-Distal-Epithelial-Neuroendocrine|Distal / Age, Tissue, Lineage and Cell class | 3.65e-04 | 179 | 84 | 4 | bc04789f0fbd293fdcea66acba8cf227af251b7a | |
| ToppCell | facs-GAT-Fat-18m-Endothelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-04 | 179 | 84 | 4 | 83343b68977969c7978acd930a66fc7c44df6a15 | |
| ToppCell | droplet-Fat-Gat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-04 | 179 | 84 | 4 | 08cf9986804a6417a9afb19b50c69a3554f71ec6 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-04 | 180 | 84 | 4 | 2405aa5699a8d8cf4c6b3dca07510e774728ac50 | |
| ToppCell | facs-Lung-EPCAM-18m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-04 | 180 | 84 | 4 | 082c6116e0bbba8d9a3a82d14af55bdc8990c8c0 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-04 | 180 | 84 | 4 | 9c47852c0a723e2f5cd6898afff4c31a0da06905 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-04 | 180 | 84 | 4 | 499d5fe71e0dc20cffdf85e3b3f14eb4e83e3a3d | |
| ToppCell | facs-Lung-EPCAM-18m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-04 | 180 | 84 | 4 | 53043d764fad9ac33ee40e356e562e759931adef | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-Tuft-related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.80e-04 | 181 | 84 | 4 | 1d3d1b5a6efe9cedd03b7e0b5684df97f0246729 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.80e-04 | 181 | 84 | 4 | 0756d7d315b8cdd07a3cf6cdfc8a0679786b8e6a | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.80e-04 | 181 | 84 | 4 | b09947d2d7b21f96d98b87ceb6f467ea329c4092 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.80e-04 | 181 | 84 | 4 | 3f0d88e9506d66d4e71b88c50d5187302065930f | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.80e-04 | 181 | 84 | 4 | 9cd5e5c285c2b628db9d59709af053defd7c0aff | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.80e-04 | 181 | 84 | 4 | 0069e8308de932df43660bbe926637c57b8bf7f6 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 3.88e-04 | 182 | 84 | 4 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.88e-04 | 182 | 84 | 4 | 4a85429d365c4b2d73fc921f261b4b7635ac40bd | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.88e-04 | 182 | 84 | 4 | 53213af34af3337f5edc734d3b7b79e4349eac0d | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-04 | 182 | 84 | 4 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.88e-04 | 182 | 84 | 4 | 7909089ed6325c44edd6f9b7e8b1d542398222ea | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-04 | 182 | 84 | 4 | f4a5f1c3a04c0566eb96607dab7a0d9a5ebc3fd1 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-04 | 183 | 84 | 4 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| Disease | Dent disease (implicated_via_orthology) | 2.01e-05 | 3 | 77 | 2 | DOID:0050699 (implicated_via_orthology) | |
| Disease | osteopetrosis (implicated_via_orthology) | 1.40e-04 | 7 | 77 | 2 | DOID:13533 (implicated_via_orthology) | |
| Disease | Shortened QT interval | 3.64e-04 | 11 | 77 | 2 | C0151879 | |
| Disease | autism spectrum disorder | 7.54e-04 | 156 | 77 | 4 | EFO_0003756 | |
| Disease | diffuse plaque measurement | 8.07e-04 | 758 | 77 | 8 | EFO_0010699 | |
| Disease | Van Buchem disease | 8.91e-04 | 17 | 77 | 2 | C0432272 | |
| Disease | diaphragmatic hernia | 1.37e-03 | 21 | 77 | 2 | EFO_0008561 | |
| Disease | corpus callosum volume measurement | 2.30e-03 | 100 | 77 | 3 | EFO_0010299 | |
| Disease | cortex volume change measurement, age at assessment | 2.43e-03 | 28 | 77 | 2 | EFO_0008007, EFO_0021500 | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 2.61e-03 | 29 | 77 | 2 | C0496920 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SRSKERTRHRSDKKK | 186 | Q13523 | |
| LKKKASSHAVDRLRR | 186 | Q5TYW2 | |
| TAKRLVKVKVTFRHD | 31 | Q4LE39 | |
| RAEKKLKHRRTSETS | 266 | O94929 | |
| TSARHTRRKRKKEKT | 101 | P48751 | |
| RRKKKVVHRTATADD | 71 | P20290 | |
| HRRSRDLLKAKQTEK | 116 | Q9NYV4 | |
| LKKKASTHAVDRLRR | 186 | Q5CZ79 | |
| KARKTKITHLVRTAD | 826 | Q8WY36 | |
| KKRDERSVKSTAVRV | 311 | P49760 | |
| LKKKASSHAVDRLRR | 186 | Q4UJ75 | |
| KSRDKKAHEKVTERR | 26 | Q9BSQ5 | |
| RDTDRHRKITSKSKE | 41 | P51793 | |
| KDEKRKEKRRHRSHS | 101 | P21127 | |
| RHRTEDKRKREQESK | 466 | Q9UKL3 | |
| RKDRDSKAHRSRTKS | 271 | Q14004 | |
| TRAAKRARHKQRKLE | 866 | P78312 | |
| KEARRRKEVNRIKHS | 411 | Q9NV06 | |
| TSKKTRKEDHARLRA | 81 | Q8N0V3 | |
| RSRSHERKRSKSKER | 41 | Q14498 | |
| REEKKESLRSSVHKR | 226 | Q9NS91 | |
| KFARSDERKRHTKIH | 406 | P11161 | |
| TDIRKKSRSAHAVKI | 796 | Q96ST2 | |
| DSREVFKKHIEKRVR | 206 | Q9ULU8 | |
| EAKEKLARQHKRRSD | 661 | Q09161 | |
| EKEAKSQKRARHLAR | 71 | Q9NQ38 | |
| RSIERVHKVKASRDV | 566 | O75197 | |
| KTTRQASLRKKIREH | 196 | Q9HCI6 | |
| ASLRKKIREHDVSKA | 201 | Q9HCI6 | |
| KEHRVRVCRKSVDRS | 586 | Q8IXW0 | |
| KASVVKKAAARRRRH | 326 | Q9NY59 | |
| VRRVRESNVLHEKSK | 81 | Q9NX62 | |
| DSKEIDRRRARIKHS | 231 | Q8N5Y8 | |
| VKDHKSNSKERDIRR | 426 | Q13427 | |
| DHSKSKEKDRRAQSR | 531 | Q13427 | |
| VHARKEEKEAVSARR | 881 | Q0VF96 | |
| RKKSGRHVTRVLVKD | 516 | Q9H6X5 | |
| KFARSDERKRHAKIH | 341 | Q06889 | |
| ARRKKKVVHRTATAD | 21 | Q96K17 | |
| ESESRKRSISKRKSH | 386 | Q5TH69 | |
| HRARRTEISKNSEKK | 6 | Q9H4A5 | |
| ESKKRRSHRRIEKKG | 676 | Q9Y6T7 | |
| RKESSRHSKLEKADI | 66 | Q9HCC6 | |
| RKRRHSEVETDSKKK | 271 | Q9NX58 | |
| KRHTKDTALKRSKRR | 121 | Q08554 | |
| KVTKEHRERPRKDSE | 196 | Q03111 | |
| EKSRKVSAHTRAVKE | 116 | O95810 | |
| VHRRVKTALARKEEA | 1036 | Q9UPN4 | |
| LKARKVRFSEKVTVH | 551 | O75807 | |
| DSHAKALERAKKRVT | 236 | P48145 | |
| TLAEHRRTVAEAKKK | 996 | O15397 | |
| SHKDRFISGREIKKR | 311 | O43189 | |
| TSHNKERRSKRDEKL | 261 | Q92541 | |
| KHTKRRKLTVEDFNR | 56 | Q9Y6J9 | |
| EKRLRRSAHARKETE | 61 | Q15208 | |
| EEKKLRRSQHARKET | 61 | Q9Y2H1 | |
| EERHQRRSSVKKIEK | 206 | Q7Z6B7 | |
| NIHERTVSRKKKSKR | 106 | Q1AE95 | |
| KREREAATKHSKASL | 106 | Q9BRQ6 | |
| RHKKTKRGVAIARDK | 161 | Q7Z443 | |
| EKEDIALNKHRSRRK | 671 | O94844 | |
| HSRDKRKDTREKIKE | 256 | Q8WXA9 | |
| KRVRSRASRKHKDET | 281 | Q9H930 | |
| RERHRRINSKKKESA | 101 | P51790 | |
| KKKARRRHTDDPSKE | 61 | O94827 | |
| KHKERDLKRGKSRES | 726 | Q9Y2W1 | |
| SKKVRKELSRVDQRH | 41 | Q2NL82 | |
| SIHERTVSRKKKSKR | 106 | Q8IXX5 | |
| KKEEKRRHSRSRSRS | 241 | Q05519 | |
| KEKKHSRSRSRERKH | 421 | Q5VTL8 | |
| KKLRERFCHRQKEVS | 1156 | O95271 | |
| EKRAKDDSRRVVKST | 356 | Q9BX66 | |
| SKRRDEKRHKKQSRS | 161 | A7MD48 | |
| KTALRQRHKEKKRSA | 1591 | Q9H5I5 | |
| EVEAACEKHTRRKTR | 86 | Q8N1W2 | |
| SKSALHRRADKKKRS | 1716 | Q9HCK1 | |
| KAERKRKAEAARLHR | 1016 | Q8IWV7 | |
| LVKAEDKARVHRSKK | 446 | Q96KM6 | |
| SRSSDRETKHKRRKR | 846 | Q9NS56 | |
| AQKRVRSRASRKHKD | 566 | Q13342 | |
| DRKTKKRHCVVRQLT | 646 | P35968 | |
| EDSSKRIRKSHKRPK | 456 | Q92889 | |
| HESDVKIVAKSIRDR | 521 | Q9Y3S1 | |
| HKVNAETAKRKSIRR | 1786 | Q5T5U3 | |
| VKHTKRVHERAGAKR | 206 | Q9C0D4 | |
| VKHKRIHSREKRGDS | 446 | Q9BS31 | |
| KKSRPVRHTKRHEEE | 41 | A8MPX8 |